Evidence map›Paper›PMID 41527818›Full record

ArticleEmerging microbes & infections2026

A

Sabrina Wamp, Rosalyn Wagner, Franziska Schuler, Alexander Krüttgen, Antje Flieger, Sven Halbedel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. AEmerging microbes & infections · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabrina WampFG11 Division of Enteropathogenic Bacteria and Legionella, Consultant Laboratory for Listeria, Robert Koch Institute, Wernigerode, Germany.ORCID 0000-0002-0387-4171
Rosalyn WagnerInstitute for Laboratory Medicine and Medical Microbiology, Munich Municipal Hospital gGmbH, München, Germany.ORCID 0009-0003-5624-6050
Franziska SchulerInstitute for Medical Microbiology, University Hospital Münster, Münster, Germany.ORCID 0000-0002-2681-1958
Alexander KrüttgenLaboratory Diagnostic Center, RWTH Aachen University Hospital, Aachen, Germany.ORCID 0000-0002-7157-8454
Antje FliegerFG11 Division of Enteropathogenic Bacteria and Legionella, Consultant Laboratory for Listeria, Robert Koch Institute, Wernigerode, Germany.ORCID 0000-0003-3819-2979
Sven HalbedelFG11 Division of Enteropathogenic Bacteria and Legionella, Consultant Laboratory for Listeria, Robert Koch Institute, Wernigerode, Germany.ORCID 0000-0002-5575-8973

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Listeriosis is a severe foodborne infection and associated with high mortality. Treatment is based on ampicillin, amoxicillin or penicillin, often combined with gentamicin, but meropenem is also used occasionally. β-lactam resistant

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-Lactam Resistancebeta-LactamsListeria monocytogenesListeriosisPenicillin-Binding ProteinsAmpicillinbeta Lactam AntibioticsHumansMeropenemMicrobial Sensitivity TestsMutationThienamycinsAmpicillinAnti-Bacterial AgentsBacterial Proteinsbeta Lactam Antibioticsbeta-LactamsMeropenemPenicillin-Binding ProteinsThienamycinsAntibiotic resistancepenicillin binding proteinpeptidoglycantranspeptidaseβ-lactams

Identifiers

PMID41527818
PMCPMC12854224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.